Prevention of Disability in the Frail Elderly Person Through an Innovative Customised and Multidimensional Training Programme
- Disease/Condition
- Frailty
- Drug/Device/Intervention
- Experimental training
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- University of Milan
- Location
- Milano, Italy
- Phase
- N/A
- Start date
- Mar 20, 2023
- End date
- Dec 31, 2024
- Enrollment
- 80 participants
Changes in the Functional decline,Intrinsic Capacity (IC),Intreaction between IC and cardiac autonomic control (CAC)
The goal of this clinical trial is to implement a personalized training program to prevent
 functional decline in frail subjects but not yet disable. The purpose of the project is to
 test the training in a subject at particularly high risk of entering the disabled condition.
 A total of 80 frail subjects, divide the participants into two groups Divida Senso Group
 (experimental group) and Standard of care Group (Control group) will be recruited.
 
 The expected outcome is to slow down a functional decline not only in isolation in the
 domains trained by the program.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06377436
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06377436 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Milan and is currently Recruiting. The study focuses on Frailty. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.